Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polycystic Kidney Diseases”

226 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 226 results

Large-scale testing (Phase 3)Study completedNCT01853553
What this trial is testing

Mineralocorticoid Antagonism and Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Who this might be right for
ADPKD
University of Colorado, Denver 61
Not applicableStudy completedNCT06594367
What this trial is testing

A Possible Founding PKD2 Mutation Associated With Variable Phenotypes of ADPKD in Bergamo Province

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Mario Negri Institute for Pharmacological Research 10
Early research (Phase 1)Study completedNCT04908462
What this trial is testing

To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211 in Healthy Volunteers

Who this might be right for
Autosomal Dominant Polycystic Kidney
AceLink Therapeutics, Inc. 69
Not applicableLooking for participantsNCT06601829
What this trial is testing

Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney Disease in Children at Sohag University Hospital

Who this might be right for
Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney Disease in Children at Sohag University Hospital
Sohag University 30
Large-scale testing (Phase 3)Ended earlyNCT04064346
What this trial is testing

Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic KidneyADPKD
Palladio Biosciences 12
Not applicableLooking for participantsNCT02936791
What this trial is testing

Early PKD Observational Cohort Study

Who this might be right for
Polycystic Kidney Disease
University of Kansas Medical Center 250
Post-approval studies (Phase 4)Active Not RecruitingNCT03273413
What this trial is testing

Statin Therapy in Patients With Early Stage ADPKD

Who this might be right for
ADPKDAutosomal Dominant Polycystic Kidney
University of Colorado, Denver 150
Testing effectiveness (Phase 2)UnknownNCT01932450
What this trial is testing

Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control

Who this might be right for
Autosomal Dominant Polycystic Kidney DiseaseHypertension
Mei changlin 100
Post-approval studies (Phase 4)Active Not RecruitingNCT06391450
What this trial is testing

Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease (EMPA-PKD)

Who this might be right for
Autosomal Dominant Polycystic Kidney
Hannover Medical School 44
Large-scale testing (Phase 3)Looking for participantsNCT04939935
What this trial is testing

Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
The University of Queensland 1,174
Testing effectiveness (Phase 2)Study completedNCT05190744
What this trial is testing

Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration

Who this might be right for
Autosomal Dominant Polycystic Kidney DiseaseNephrogenic Diabetes InsipidusAcquired Nephrogenic Diabetes Insipidus+1 more
Mayo Clinic 36
Large-scale testing (Phase 3)Study completedNCT00346918
What this trial is testing

Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
University of Zurich 100
Testing effectiveness (Phase 2)Study completedNCT02697617
What this trial is testing

Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Polycystic Kidney Disease
Indiana University 18
Early research (Phase 1)Study completedNCT04536688
What this trial is testing

RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Polycystic Kidney Disease, Autosomal Dominant
Regulus Therapeutics Inc. 19
Large-scale testing (Phase 3)Study completedNCT02225860
What this trial is testing

Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Tufts Medical Center 34
Early research (Phase 1)Looking for participantsNCT07788014
What this trial is testing

Single and Multiple Ascending Doses of GV-100

Who this might be right for
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Gilva Therapeutics Inc. 80
Post-approval studies (Phase 4)UnknownNCT00541853
What this trial is testing

CCB Safety Study in Treatment of Hypertension of ADPKD

Who this might be right for
Kidney, Polycystic, Autosomal Dominant
Kyorin University 150
Large-scale testing (Phase 3)Study completedNCT02160145
What this trial is testing

Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseAutosomal Dominant Polycystic Kidney Disease
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,370
Not applicableStudy completedNCT01430494
What this trial is testing

Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Otsuka Pharmaceutical Development & Commercialization, Inc. 3,409
Testing effectiveness (Phase 2)Looking for participantsNCT05478083
What this trial is testing

A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease

Who this might be right for
Polycystic Liver DiseaseAutosomal Dominant Polycystic Kidney
University Medical Center Groningen 36
Next Page